InvestorsHub Logo
Followers 71
Posts 7941
Boards Moderated 0
Alias Born 01/29/2015

Re: None

Sunday, 03/17/2019 3:55:46 AM

Sunday, March 17, 2019 3:55:46 AM

Post# of 27526
Hey Rags...I understand the frustration. Here's a question for you. Can you tell me what a reasonable timeline is for completion of the following?

Currently the BCU will collect key real-time parameters of breath flow rate, total volume, relative humidity measurements, as well as carbon dioxide levels, and temperature – these measurements and others, will help Cannabix, regulators and industry scientists determine key physiologic parameters needed for standardizing a breath sample for FAIMS THC content and its decay metrics.



That is a lot of entities (moving parts) collaborating to come to a general consensus my friend. So, if you can, can't or won't provide a reply to my open question...please allow me to offer something in addition to the conversation.

It's my belief that Algernon does not require such a complex collaboration for it's POC RUO device which is the same technology. Not only is it the same technology but get this Camp Cannabix: One of the entities that Cannabix is reaching out to is the EXACT SAME monetary revenue stream Kal claims Algernon is targeting - "Industry Scientists."

@ Algernon -

Before the V3 prototype development phase is successfully completed, the device will need to achieve a number of performance characteristics including device sensitivity, precision and reproducibility in a laboratory setting. Once the prototype work is completed, the device will be ready to be moved into a research use only (RUO) development phase. The goal of this phase will be to engineer and produce field ready devices that will be made available to research scientists worldwide to help advance the discovery and validation of breath-based biomarkers.


So how does the eye of that needle get thread between Cannabix and Algernon?


So Kal is going to simply have Research Use only (RUO) devices in the field on behalf of Cannabix, but not release RUO devices for Algernon to move forward?

Yes, the outlier is Kal Malhi himself holding Algernon's device back. Had I not seen with my own two eyes Kal hitting a bong...per shell posting a video of such activities...I'd say Kal's not in the bag to make sure Cannabix rolls out a device first.

However, even in the face of knowing Algernon needs cash now (JG Wentworth) - and short of a pharma deal that comes with a cash infusion, Kal is still subject to royaly f*** shareholders # Algernon. Kal did it before without repercussions. He may well do it again, but odds are Algernon will get at least one cash deal!

In addition, Chris Moreau & Dr. Mark Williams have their own timeline and mission @ hand. Therefore, it's their involvement/commotment where I'd bet Algernon will complete at least one trial if not 3 before the FAIMS THC breathalyzer goes commercial.

See Rags, I'm willing to put it all out there. I don't need to hide behind PM's. I call it how I see it. All ways have. Even though I do pay for PM's, history proves privacy means jack due to snitches and folks simply being cheap (freeloading), but any escuse will do for most.

Anyway, add whatever you got to the convo, or simply do whatever you choose my friend. No need for name calling here. It's simply a healthy debate based on facts as we know them. Well at least fact in black and white as I personally understand it. Just 1 opinion of course.

Peace 2 All,

/////AMG

P.S. If anyone has paid any attention to the sister board, perhaps you have figured out it does not take 5-6 years for Algernon to realize massive gains/market cap. It's the trial pipeline that adds value to the bottom line. 3 trials are fully loaded in the pipeline (see IBOX) ramping up for launch. Just facts.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLOZF News